BLOG

Despite Many Candidates, Covid-19 Treatments Lag Behind Vaccines

A similar approach—a broad-spectrum antiviral in the form of a nasal spray—has been taken by Leyden Labs in the Netherlands, who recently struck a deal for a €40M Series A funding round to advance its product.